Skip to main content
Top
Published in: European Radiology 6/2019

01-06-2019 | Pleural Effusion | Magnetic Resonance

Ascites relative enhancement during hepatobiliary phase after Gd-BOPTA administration: a new promising tool for characterising abdominal free fluid of unknown origin

Authors: Matteo Bonatti, Riccardo Valletta, Giulia A. Zamboni, Fabio Lombardo, Maria Senoner, Mariachiara Simioni, Guenther Schifferle, Giampietro Bonatti

Published in: European Radiology | Issue 6/2019

Login to get access

Abstract

Objectives

To correlate the degree of ascites enhancement during hepatobiliary phase after gadobenate dimeglumine (Gd-BOPTA) administration with ascites aetiology.

Methods

IRB-approved retrospective study, need for informed consent was waived. We included 74 consecutive ascitic patients who underwent Gd-BOPTA-enhanced liver MRI including hepatobiliary phase (HBP) images between January 2014 and December 2017. Ascites appearance on unenhanced and HBP images was classified as hypo-, iso- or hyperintense in comparison to paraspinal muscles. Ascites signal intensity on unenhanced and HBP images was measured using round ROIs and was normalised to paraspinal muscles (NSI). Normalised relative enhancement (NRE) between native phase and HBP was calculated. The results were related to ascites aetiology using Wilcoxon and Mann-Whitney tests.

Results

On native images, ascites appeared hypointense in 95.9% of the cases and isointense in 4.1%, whereas on HBP images, it appeared hyperintense in 59.4% of the cases, isointense in 36.5% and hypointense in 4.1%. Mean ascites NSI was 0.52 on unenhanced images and 1.50 on HBP ones (p < 0.0001). Mean ascites NRE was 201 ± 133%. Ascites of non-malignant aetiology showed mean NRE of 210 ± 134%, whereas malignant ascites showed mean NRE of 92 ± 20% (p = 0.001). ROC analysis showed that a NRE < 112.5% correlates with malignant aetiology with 100% sensitivity and 83.4% specificity (LR = 5.667). NRE did not show any significant correlation with ascites thickness, eGFR and time interval between contrast administration and HBP acquisition (p > 0.05).

Conclusions

Ascites NRE in HBP after Gd-BOPTA administration is significantly lower in patients with ascites secondary to peritoneal carcinomatosis than in patients with non-malignant ascites.

Key Points

• Ascites enhancement in the hepatobiliary phase after Gd-BOPTA administration may determine false positive findings when looking for biliary leaks.
• Ascites enhancement in the hepatobiliary phase after Gd-BOPTA administration is lower in patients with peritoneal carcinomatosis than in patients with portal hypertension or congestive heart failure.
• None of the patients with peritoneal carcinomatosis showed an ascites enhancement of more than 112% as compared with unenhanced images.
Literature
1.
go back to reference Kirchin MA, Lorusso V, Pirovano G (2015) Compensatory biliary and urinary excretion of gadobenate ion after administration of gadobenate dimeglumine (MultiHance(®)) in cases of impaired hepatic or renal function: a mechanism that may aid in the prevention of nephrogenic systemic fibrosis? Br J Radiol 88:20140526CrossRefPubMedPubMedCentral Kirchin MA, Lorusso V, Pirovano G (2015) Compensatory biliary and urinary excretion of gadobenate ion after administration of gadobenate dimeglumine (MultiHance(®)) in cases of impaired hepatic or renal function: a mechanism that may aid in the prevention of nephrogenic systemic fibrosis? Br J Radiol 88:20140526CrossRefPubMedPubMedCentral
2.
go back to reference Fontarensky M, Montoriol PF, Buc E, Poincloux L, Petitcolin V, Da Ines D (2013) Advantages of gadobenate dimeglumine-enhanced MR cholangiography in the diagnosis of post-liver transplant bile leakage. Diagn Interv Imaging 94:443–452CrossRefPubMed Fontarensky M, Montoriol PF, Buc E, Poincloux L, Petitcolin V, Da Ines D (2013) Advantages of gadobenate dimeglumine-enhanced MR cholangiography in the diagnosis of post-liver transplant bile leakage. Diagn Interv Imaging 94:443–452CrossRefPubMed
3.
go back to reference Francisco FA, de Araújo AL, Oliveira Neto JA, Parente DB (2014) Hepatobiliary contrast agents: differential diagnosis of focal hepatic lesions, pitfalls and other indications. Radiol Bras 47:301–309CrossRefPubMedPubMedCentral Francisco FA, de Araújo AL, Oliveira Neto JA, Parente DB (2014) Hepatobiliary contrast agents: differential diagnosis of focal hepatic lesions, pitfalls and other indications. Radiol Bras 47:301–309CrossRefPubMedPubMedCentral
4.
5.
go back to reference Melamud K, LeBedis CA, Anderson SW, Soto JA (2014) Biliary imaging: multimodality approach to imaging of biliary injuries and their complications. Radiographics 34:613–623CrossRefPubMed Melamud K, LeBedis CA, Anderson SW, Soto JA (2014) Biliary imaging: multimodality approach to imaging of biliary injuries and their complications. Radiographics 34:613–623CrossRefPubMed
6.
go back to reference Scali EP, Walshe T, Tiwari HA, Harris AC, Chang SD (2017) A pictorial review of hepatobiliary magnetic resonance imaging with hepatocyte-specific contrast agents: uses, findings, and pitfalls of gadoxetate disodium and gadobenate dimeglumine. Can Assoc Radiol J 68:293–307CrossRefPubMed Scali EP, Walshe T, Tiwari HA, Harris AC, Chang SD (2017) A pictorial review of hepatobiliary magnetic resonance imaging with hepatocyte-specific contrast agents: uses, findings, and pitfalls of gadoxetate disodium and gadobenate dimeglumine. Can Assoc Radiol J 68:293–307CrossRefPubMed
7.
go back to reference Seale MK, Catalano OA, Saini S, Hahn PF, Sahani DV (2009) Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree. Radiographics 29:1725–1748CrossRefPubMed Seale MK, Catalano OA, Saini S, Hahn PF, Sahani DV (2009) Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree. Radiographics 29:1725–1748CrossRefPubMed
8.
go back to reference Huang LL, Xia HH, Zhu SL (2014) Ascitic fluid analysis in the differential diagnosis of ascites: focus on cirrhotic ascites. J Clin Transl Hepatol 2:58–64PubMedPubMedCentral Huang LL, Xia HH, Zhu SL (2014) Ascitic fluid analysis in the differential diagnosis of ascites: focus on cirrhotic ascites. J Clin Transl Hepatol 2:58–64PubMedPubMedCentral
9.
go back to reference Cárdenas A, Bataller R, Arroyo V (2000) Mechanisms of ascites formation. Clin Liver Dis 4:447–465CrossRefPubMed Cárdenas A, Bataller R, Arroyo V (2000) Mechanisms of ascites formation. Clin Liver Dis 4:447–465CrossRefPubMed
10.
go back to reference Hou W, Sanyal AJ (2009) Ascites: diagnosis and management. Med Clin North Am 93:801–817 Hou W, Sanyal AJ (2009) Ascites: diagnosis and management. Med Clin North Am 93:801–817
11.
go back to reference Tamsma JT, Keizer HJ, Meinders AE (2001) Pathogenesis of malignant ascites: Starling’s law of capillary hemodynamics revisited. Ann Oncol 12:1353–1357CrossRefPubMed Tamsma JT, Keizer HJ, Meinders AE (2001) Pathogenesis of malignant ascites: Starling’s law of capillary hemodynamics revisited. Ann Oncol 12:1353–1357CrossRefPubMed
12.
go back to reference Abdel-Razik A, Mousa N, Elalfy H et al (2017) A novel combination of C-reactive protein and vascular endothelial growth factor in differential diagnosis of ascites. J Gastrointest Cancer 48:50–57CrossRefPubMed Abdel-Razik A, Mousa N, Elalfy H et al (2017) A novel combination of C-reactive protein and vascular endothelial growth factor in differential diagnosis of ascites. J Gastrointest Cancer 48:50–57CrossRefPubMed
13.
go back to reference Risson JR, Macovei I, Loock M, Paquette B, Martin M, Delabrousse E (2012) Cirrhotic and malignant ascites: differential CT diagnosis. Diagn Interv Imaging 93:365–370CrossRefPubMed Risson JR, Macovei I, Loock M, Paquette B, Martin M, Delabrousse E (2012) Cirrhotic and malignant ascites: differential CT diagnosis. Diagn Interv Imaging 93:365–370CrossRefPubMed
14.
go back to reference Brogna A, Bucceri AM, Catalano F, Ferrara R, Leocata V (1996) Ultrasound demonstration of gallbladder wall thickening as a method to differentiate cirrhotic ascites from other ascites. Invest Radiol 31:80–83CrossRefPubMed Brogna A, Bucceri AM, Catalano F, Ferrara R, Leocata V (1996) Ultrasound demonstration of gallbladder wall thickening as a method to differentiate cirrhotic ascites from other ascites. Invest Radiol 31:80–83CrossRefPubMed
15.
go back to reference Ciolina M, Di Martino M, Bruno O, Pommier R, Vilgrain V, Ronot M (2018) Peritoneal and pleural fluids may appear hyperintense on hepatobiliary phase using hepatobiliary MR contrast agents. Eur Radiol 7:3020–3031CrossRef Ciolina M, Di Martino M, Bruno O, Pommier R, Vilgrain V, Ronot M (2018) Peritoneal and pleural fluids may appear hyperintense on hepatobiliary phase using hepatobiliary MR contrast agents. Eur Radiol 7:3020–3031CrossRef
16.
go back to reference Cooper C, Silverman PM, Davros WJ, Zeman RK (1993) Delayed contrast enhancement of ascitic fluid on CT: frequency and significance. AJR Am J Roentgenol 161:787–790CrossRefPubMed Cooper C, Silverman PM, Davros WJ, Zeman RK (1993) Delayed contrast enhancement of ascitic fluid on CT: frequency and significance. AJR Am J Roentgenol 161:787–790CrossRefPubMed
17.
go back to reference Benedetti N, Aslam R, Wang ZJ et al (2009) Delayed enhancement of ascites after i.v. contrast material administration at CT: time course and clinical correlation. AJR Am J Roentgenol 193:732–737CrossRefPubMedPubMedCentral Benedetti N, Aslam R, Wang ZJ et al (2009) Delayed enhancement of ascites after i.v. contrast material administration at CT: time course and clinical correlation. AJR Am J Roentgenol 193:732–737CrossRefPubMedPubMedCentral
18.
go back to reference Wise SW, DeMeo JH, Austin RF (1996) Enhancing ascites: an aid to CT diagnosis. Abdom Imaging 21:67–68CrossRefPubMed Wise SW, DeMeo JH, Austin RF (1996) Enhancing ascites: an aid to CT diagnosis. Abdom Imaging 21:67–68CrossRefPubMed
19.
go back to reference Bozkurt M, Doganay S, Kantarci M et al (2011) Comparison of peritoneal tumor imaging using conventional MR imaging and diffusion-weighted MR imaging with different b values. Eur J Radiol 80:224–228CrossRefPubMed Bozkurt M, Doganay S, Kantarci M et al (2011) Comparison of peritoneal tumor imaging using conventional MR imaging and diffusion-weighted MR imaging with different b values. Eur J Radiol 80:224–228CrossRefPubMed
20.
go back to reference Low RN, Sebrechts CP, Barone RM, Muller W (2009) Diffusion-weighted MRI of peritoneal tumors: comparison with conventional MRI and surgical and histopathologic findings--a feasibility study. AJR Am J Roentgenol 193:461–470CrossRefPubMed Low RN, Sebrechts CP, Barone RM, Muller W (2009) Diffusion-weighted MRI of peritoneal tumors: comparison with conventional MRI and surgical and histopathologic findings--a feasibility study. AJR Am J Roentgenol 193:461–470CrossRefPubMed
Metadata
Title
Ascites relative enhancement during hepatobiliary phase after Gd-BOPTA administration: a new promising tool for characterising abdominal free fluid of unknown origin
Authors
Matteo Bonatti
Riccardo Valletta
Giulia A. Zamboni
Fabio Lombardo
Maria Senoner
Mariachiara Simioni
Guenther Schifferle
Giampietro Bonatti
Publication date
01-06-2019
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 6/2019
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-018-5932-y

Other articles of this Issue 6/2019

European Radiology 6/2019 Go to the issue